GLP-1 drugs are life-changing. But the science is clear: without resistance training, you lose more than just pounds.
HEALTH & WELLNESS · MARCH 2026
If you take a GLP-1 drug like Ozempic, Wegovy, or Mounjaro, you already know the appeal. The weight goes away. Cravings subside. You feel like the deck is finally stacked in your favor. And they are — these are really effective drugs.
But here’s something important: the weight you lose isn’t all fat. A significant portion may come from lean body mass, which includes muscle. Over time, without strategies to maintain lean mass, this can lead to reduced strength and functional capacity.
The good news? The fix doesn’t require hours in the gym. Short, consistent bouts of resistance movement can help maintain muscle. Here’s what the research shows.
The hidden cost of GLP-1 weight loss
Studies of semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) consistently find that 25% to 40% of the weight lost with these drugs is lean body mass — involving muscle. The landmark STEP 1 trial of semaglutide found that about 40% of the total weight lost came from lean tissue, not fat. This is nothing.
25–40%
GLP-1 weight loss may come from lean muscle mass rather than fat
30%
potential higher risk of osteoporosis in GLP-1 users versus non-users
~ 1 in 8
US adults now take a GLP-1 drug
10 minutes
Daily resistance training can actually preserve muscle and bone
Why does this matter? Muscle plays a key role in metabolic health, strength, mobility and long-term function. Loss of lean mass can contribute to fatigue, reduced strength, and an increased risk of frailty over time.
New Research: GLP-1 and Bone Risk
Some emerging research has investigated potential effects of GLP-1 drugs on bone health. The results are mixed and not definitive.Weight loss itself—regardless of the method—is associated with decreases in bone density. Reduced caloric intake and lower mechanical loading both contribute.
Exercise, particularly resistance and weight training, is one of the most evidence-based ways to help maintain bone density during weight loss.
Because resistance training is non-negotiable
Resistance training is one of the most effective tools for maintaining muscle and bone during weight loss.
A randomized clinical trial published in JAMA Network Open (2024) found that combining GLP-1 therapy with exercise resulted in better preservation of bone density compared to treatment with GLP-1 alone.
“It would seem highly appropriate to implement targeted exercise to preserve and potentially enhance muscle mass in patients receiving GLP-1-based therapies.”
— Frontiers in Endocrinology, 2024
A separate case series published in PMC showed that GLP-1 users who did structured resistance training 3-5 days a week didn’t just preserve muscle—some patients actually increased their lean mass while losing significant body fat. This is the difference between losing weight and actually changing your body composition.
The conclusion from the research: the drug causes fat loss. You do muscle sparing.
This is where micro-dosing workouts come in
That’s the thing with people taking GLP-1 drugs: they’re often looking for the most effective, least demanding route. That’s not criticism – it’s clever. These drugs work precisely because they lower the threshold for success. Micro-dose workouts follow the same philosophy.
You don’t need 60 minutes of exercise to protect your muscle mass. Research shows that short, frequent bouts of resistance exercise; — even for 5 to 10 minutes at a time — stimulate the muscle maintenance response your body needs. A 2025 study from Edith Cowan University found that a daily 5-minute bodyweight workout helped improve strength, flexibility and mood even in people who rarely exercised.
“People taking GLP-1 drugs already have a tool for appetite and fat loss. Resistance training complements that, helping to preserve muscle.”
— Evidence-based consensus across exercise physiology research
Think of it as a combination of two effectiveness tools: the drug handles calorie reduction. short daily training handles muscle and bone maintenance. Together, they produce a result that neither can achieve alone.
What might this look like in your day?
GLP-1 Friendly Microdose Resistance Movements (5–10 min each)
- wall push-ups or floor push-ups (3 sets of 10-15 reps) while making coffee
- Bodyweight Squats or Chair Sits — great for quads and glutes
- Rows or curls with a resistance band at your desk or in front of the TV
- Climbing stairs at a brisk pace — one of the most studied bone-protecting activities
- Slow, controlled drops during a phone call
- Plank Holds (20–30 seconds) — builds core strength without requiring a gym
- Heel lift while standing on kitchen counter — protects ankle and calf muscles
You don’t need weights. You don’t need a gym membership. You need consistency and a little effort applied in the right direction. Even three or four of these “micro-doses” a week can make a significant difference to your muscle and bone health over time.
The Takeaway
GLP-1 drugs are a powerful tool. But tools work best when used correctly. The research is clear: without some form of resistance exercise, you risk losing the muscle and bone density you need for a long, healthy life. And with micro-dose workouts, the bar couldn’t be lower.
Ten minutes. A few times a week. No gym required. Just as your medicine asks very little of you each week for a big reward, so does this.
Your scale only tells part of the story. Make sure the rest of the story is good.
The studies behind this article
- Bone health after exercise alone, GLP-1 receptor agonist therapy, or combination therapy (JAMA Network Open, 2024) — RCT of 195 adults over 52 weeks. Exercise + GLP-1 treatment preserved BMD at the hip, spine, and forearm versus GLP-1 treatment alone, which resulted in decreased BMD.
- Preservation of lean soft tissue during weight loss with GLP-1 treatments (PMC, 2025) — Case series showing GLP-1 users who combined resistance training (3–5 days/week) with adequate protein either minimized muscle loss or actually increased lean soft tissue while losing fat.
- GLP-1 May Raise Osteoporosis Risk, New Research Finds (AAOS / NBC News, 2026) — A large retrospective study presented at the American Academy of Orthopedic Surgeons found that GLP-1 users had about 30% higher rates of osteoporosis and almost twice the risk of bone density problems over five years.
- Muscle Mass and GLP-1 Receptor Agonists: Adaptive or Maladaptive Response? (release, 2024) — Comprehensive review from the Journal of the American Heart Association. Semaglutide associated with loss of lean mass of up to 40% of total weight lost in the STEP 1 trial. highlights the importance of targeted lifestyle interventions.
- GLP-1 and Lean Mass: What the Research Shows (ACE Fitness, 2025) — Analysis of a genetic study of 800,000+ subjects confirming that while GLP-1s reduce both fat and lean mass, fat loss is more important. He recommends resistance training 2–3 times per week and protein goals of 1.2–1.6 g/kg/day to maintain muscle.
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or care team before changing your exercise routine while taking any medication.
